Skip to main content
2024 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Praveen Tyle, PhD

Founder & CEO
Potens Pharmaceuticals
Spring, Texas

Dr. Praveen Tyle is currently founder of Potens Pharmaceuticals. Until April 2023, Dr. Tyle was the President & CEO of Invectys, Inc, an immuno-oncology company. Prior to joining Invectys, Inc, he was EVP of R&D at Lexicon Pharmaceuticals. Until February 2016, Dr. Tyle was President, CEO and Member of the Board of Directors of Osmotica Pharmaceutical Corp. He led the merger of Osmotica with two other companies in 2016. He previously served as global Executive Vice President, Chief Scientific Officer and Managing Director of Osmotica Pharmaceutical Corp.’s Marietta, Georgia site. Prior to joining Osmotica, Dr. Tyle served as Executive Vice President and Chief Science Officer for the USP. Prior to joining USP, Dr. Tyle served as Senior Vice President and Global Head of Business Development and Licensing at Novartis OTC, as well as Senior Vice President and Global Head of Research and Development. He also is an independent member of the board of Orient EuroPharma Co., Ltd. of Taiwan and a member of the Board of Directors of SKYE Biosciences, San Diego, CA and Maxwell Biosciences, Austin Texas. Dr. Tyle holds a doctorate in pharmacy from the Ohio State University and a Bachelor in Pharmacy (honors) from the IIT BHU.

Disclosure information not submitted.

Presentation(s):